Mobile Lads Corp. (MOBO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -554.55 Thousand USD | 56.72% |
| 2021 | -1.28 Million USD | -29.21% |
| 2020 | -991.58 Thousand USD | 3.26% |
| 2019 | -1.02 Million USD | 0.0% |
| 2016 | -3.6 Million USD | -1148.65% |
| 2015 | -288.87 Thousand USD | -1079.09% |
| 2014 | -24.5 Thousand USD | -231.08% |
| 2013 | -7400.00 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -112.73 Thousand USD | 15.82% |
| 2023 Q2 | -110.14 Thousand USD | 2.3% |
| 2022 Q1 | -136.81 Thousand USD | 0.0% |
| 2022 FY | -554.55 Thousand USD | 56.72% |
| 2022 Q4 | -133.91 Thousand USD | 19.01% |
| 2022 Q3 | -165.34 Thousand USD | -226.82% |
| 2022 Q2 | -50.59 Thousand USD | 63.02% |
| 2021 FY | -1.28 Million USD | -29.21% |
| 2020 FY | -991.58 Thousand USD | 3.26% |
| 2019 FY | -1.02 Million USD | 0.0% |
| 2017 Q1 | -637.61 Thousand USD | -21.85% |
| 2016 Q4 | -523.28 Thousand USD | 76.27% |
| 2016 Q2 | -836 Thousand USD | -1858.41% |
| 2016 Q3 | -2.2 Million USD | -163.77% |
| 2016 Q1 | -42.68 Thousand USD | -17.54% |
| 2016 FY | -3.6 Million USD | -1148.65% |
| 2015 FY | -288.87 Thousand USD | -1079.09% |
| 2015 Q4 | -36.31 Thousand USD | 26.79% |
| 2015 Q3 | -49.6 Thousand USD | 51.82% |
| 2015 Q2 | -102.95 Thousand USD | -691.11% |
| 2015 Q1 | -13.01 Thousand USD | -674.64% |
| 2014 FY | -24.5 Thousand USD | -231.08% |
| 2014 Q1 | -2571.00 USD | 0.0% |
| 2014 Q2 | -1979.00 USD | 23.03% |
| 2014 Q4 | -1680.00 USD | 90.8% |
| 2014 Q3 | -18.25 Thousand USD | -822.39% |
| 2013 FY | -7400.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 58.474% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 89.007% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 96.893% |
| Nascent Biotech, Inc. | -2.22 Million USD | 75.131% |
| Rebus Holdings, Inc. | -664 Thousand USD | 16.483% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 100.678% |
| Qrons Inc. | -643.67 Thousand USD | 13.847% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -42.349% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 99.001% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -33.472% |
| Skye Bioscience, Inc. | -13.67 Million USD | 95.944% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 99.227% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 111.283% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -111.882% |
| SQZ Biotechnologies Company | -75.82 Million USD | 99.269% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 80.546% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 63.898% |
| Mesoblast Limited | -84.14 Million USD | 99.341% |
| Marizyme, Inc. | -34.08 Million USD | 98.373% |
| Genus plc | 6.4 Million USD | 108.665% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 105.692% |
| Pharming Group N.V. | -4.87 Million USD | 88.635% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 72.084% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | 40.459% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 93.359% |
| ContraFect Corporation | -56.88 Million USD | 99.025% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 87.825% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 60.446% |
| IMV Inc. | -38.67 Million USD | 98.566% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 79.841% |
| MultiCell Technologies, Inc. | -722.81 USD | -76621.407% |
| ONE Bio Corp. | 13.68 Million USD | 104.053% |
| Accustem Sciences Inc. | -3.74 Million USD | 85.198% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 99.06% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -14.799% |
| Q BioMed Inc. | -3.44 Million USD | 83.906% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 115.665% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 78.895% |
| Biomind Labs Inc. | -1 Million USD | 45.072% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 98.991% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 80.886% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 91.658% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 70.255% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -1751.462% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 96.506% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 71.306% |
| GB Sciences, Inc. | -1.42 Million USD | 60.961% |
| Alpha Cognition Inc. | -9.7 Million USD | 94.286% |
| HST Global, Inc. | -140.9 Thousand USD | -293.557% |
| CSL Limited | 3.7 Billion USD | 100.015% |
| Wesana Health Holdings Inc. | -1.12 Million USD | 50.703% |
| Halberd Corporation | -75.05 Thousand USD | -638.907% |
| Enzolytics Inc. | -2.14 Million USD | 74.193% |
| Agentix Corp. | -1.37 Million USD | 59.574% |
| Resverlogix Corp. | -12.74 Million USD | 95.65% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 82.497% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 99.87% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | 46.882% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 81.005% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 64.888% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 83.714% |
| AVAX Technologies, Inc. | 6.69 Million USD | 108.286% |
| Zenith Capital Corp. | -8.94 Million USD | 93.799% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.867% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -3083.227% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 77.414% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -223.335% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 72.338% |
| Kadimastem Ltd | -3.04 Million USD | 81.76% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | 43.646% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | 55.848% |
| BioStem Technologies, Inc. | -7.77 Million USD | 92.871% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -205.562% |
| LadRx Corporation | -3.82 Million USD | 85.497% |
| Cell Source, Inc. | -4.32 Million USD | 87.179% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 19.274% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 19.274% |
| NovAccess Global Inc. | -2.46 Million USD | 77.519% |
| Affymax, Inc. | -15.04 Million USD | 96.314% |
| Itoco Inc. | -919.14 Thousand USD | 39.666% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 86.916% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 50.442% |
| CytoDyn Inc. | -18.05 Million USD | 96.929% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -2103.218% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -151.979% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | 1.801% |
| SYBLEU INC | -149.18 Thousand USD | -271.732% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 69.468% |
| International Stem Cell Corporation | -663 Thousand USD | 16.357% |
| Bioxytran, Inc. | -3.82 Million USD | 85.484% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -953.476% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -2626.401% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 98.471% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 65.726% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | 24.637% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 82.175% |
| Neutra Corp. | -229.48 Thousand USD | -141.649% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 96.838% |
| PureTech Health plc | -146.19 Million USD | 99.621% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 97.42% |
| IXICO plc | -1.43 Million USD | 61.409% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 94.157% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 99.545% |
| CSL Limited | 3.81 Billion USD | 100.015% |
| Cellectis S.A. | -108.85 Million USD | 99.491% |